Dermasensa, the well-known American skincare brand, marked its 10th anniversary with a landmark celebration, underscoring a decade of global success and innovation. Founder and CEO Dr. Mark Miller highlighted the brand’s dedication to advancing skincare science. Dr. Mark signed an MOU with Bernardo Medeiros, VP of Beauty & Life Science at Lubrizol, known for its cutting-edge peptide technology through Lipotec. The gathering included leading beauty KOLs, distributors, and distinguished doctors from Shanghai Skin Disease Hospital.
Dr. Mark’s address celebrated Dermasensa’s commitment to science-driven skincare. Key highlights included the VK Eye Cream, now evaluated with a pioneering method developed with Dr. Jiang Wencai, focusing on a new approach for more accurate dark circle assessments. Another highlight was the UP Ultra Peptide Serum, showcased for its advanced peptide technology and proven uplifting benefits. Looking forward, Dermasensa unveiled its 2025 brand strategy, emphasizing a breakthrough total solution for skin tone management.
Brand ambassador Sadie Calvano also sent a heartfelt video message. Dr. Mark announced the brand’s upcoming website relaunch at www.dermasensa.com, to embrace the next decade of growth.